F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role

Mushroom-Laced Candy Recall Highlights F.D.A.’s Limited Safety Role

More than 150 people were sickened from products sold at smoke and vape shops, providing evidence of the lax regulation of new food items.